183 related articles for article (PubMed ID: 37664842)
1. Cost-effectiveness of active surveillance versus early surgery for thyroid micropapillary carcinoma based on diagnostic and treatment norms in China.
Lai M; Zhang MM; Qin QQ; An Y; Li YT; Yuan WZ
Front Endocrinol (Lausanne); 2023; 14():1166433. PubMed ID: 37664842
[TBL] [Abstract][Full Text] [Related]
2. Thyroid lobectomy as a cost-effective approach in low-risk papillary thyroid cancer versus active surveillance.
Youssef MR; Attia AS; Omar M; Aboueisha M; Freeman MN; Shama M; Kandil E
Surgery; 2022 Jan; 171(1):190-196. PubMed ID: 34384606
[TBL] [Abstract][Full Text] [Related]
3. Cost-Effectiveness of Active Surveillance Compared to Early Surgery of Small Papillary Thyroid Cancer: A Retrospective Study on a Korean Population.
Baek HS; Ha J; Kim K; Bae J; Kim JS; Kim S; Lim DJ; Kim C
J Korean Med Sci; 2023 Aug; 38(34):e264. PubMed ID: 37644680
[TBL] [Abstract][Full Text] [Related]
4. A cost-effectiveness comparison between early surgery and non-surgical approach for incidental papillary thyroid microcarcinoma.
Lang BH; Wong CK
Eur J Endocrinol; 2015 Sep; 173(3):367-75. PubMed ID: 26104754
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of active surveillance versus hemithyroidectomy for micropapillary thyroid cancer.
Venkatesh S; Pasternak JD; Beninato T; Drake FT; Kluijfhout WP; Liu C; Gosnell JE; Shen WT; Clark OH; Duh QY; Suh I
Surgery; 2017 Jan; 161(1):116-126. PubMed ID: 27839930
[TBL] [Abstract][Full Text] [Related]
6. Cost-Utility Analysis of Early Detection with Ultrasonography of Differentiated Thyroid Cancer: A Retrospective Study on a Korean Population.
Baek HS; Ha J; Kim K; Bae JS; Kim JS; Kim S; Lim DJ; Kim CM
Endocrinol Metab (Seoul); 2024 Apr; 39(2):310-323. PubMed ID: 38590123
[TBL] [Abstract][Full Text] [Related]
7. Indications and Strategy for Active Surveillance of Adult Low-Risk Papillary Thyroid Microcarcinoma: Consensus Statements from the Japan Association of Endocrine Surgery Task Force on Management for Papillary Thyroid Microcarcinoma.
Sugitani I; Ito Y; Takeuchi D; Nakayama H; Masaki C; Shindo H; Teshima M; Horiguchi K; Yoshida Y; Kanai T; Hirokawa M; Hames KY; Tabei I; Miyauchi A
Thyroid; 2021 Feb; 31(2):183-192. PubMed ID: 33023426
[No Abstract] [Full Text] [Related]
8. Active Surveillance Versus Immediate Surgery: Questionnaire Survey on the Current Treatment Strategy for Adult Patients with Low-Risk Papillary Thyroid Microcarcinoma in Japan.
Sugitani I; Ito Y; Miyauchi A; Imai T; Suzuki S
Thyroid; 2019 Nov; 29(11):1563-1571. PubMed ID: 31441377
[No Abstract] [Full Text] [Related]
9. Active Surveillance Versus Immediate Surgery for Low-Risk Papillary Thyroid Microcarcinoma Patients in South Korea: A Cost-Minimization Analysis from the MAeSTro Study.
Kim K; Choi JY; Kim SJ; Lee EK; Lee YK; Ryu JS; Lee KE; Moon JH; Park YJ; Cho SW; Park SK
Thyroid; 2022 Jun; 32(6):648-656. PubMed ID: 35570657
[No Abstract] [Full Text] [Related]
10. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
[TBL] [Abstract][Full Text] [Related]
11. Cost-Effectiveness of Long-Term Every Three-Year Versus Annual Postoperative Surveillance for Low-Risk Papillary Thyroid Cancer.
Wu JX; Beni CE; Zanocco KA; Sturgeon C; Yeh MW
Thyroid; 2015 Jul; 25(7):797-803. PubMed ID: 25851702
[TBL] [Abstract][Full Text] [Related]
12. First-Line Durvalumab in Addition to Etoposide and Platinum for Extensive-Stage Small Cell Lung Cancer: A U.S.-Based Cost-Effectiveness Analysis.
Lin S; Luo S; Gu D; Li M; Rao X; Wang C; Huang P; Xu X; Weng X
Oncologist; 2021 Nov; 26(11):e2013-e2020. PubMed ID: 34431578
[TBL] [Abstract][Full Text] [Related]
13. [Retrospective comparison of screening criteria for active surveillance for papillary thyroid microcarcinoma].
Qian K; Sun TQ; Guo K; Zheng XK; Li DS; Wei WW; Wu Y; Ji QH; Wang ZY
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jun; 52(6):430-434. PubMed ID: 28635215
[No Abstract] [Full Text] [Related]
14. BRAF V600E status may facilitate decision-making on active surveillance of low-risk papillary thyroid microcarcinoma.
Kim KJ; Kim SG; Tan J; Shen X; Viola D; Elisei R; Puxeddu E; Fugazzola L; Colombo C; Jarzab B; Czarniecka A; Lam AK; Mian C; Vianello F; Yip L; Riesco-Eizaguirre G; Santisteban P; O'Neill CJ; Sywak MS; Clifton-Bligh R; Bendlova B; Sýkorová V; Xing M
Eur J Cancer; 2020 Jan; 124():161-169. PubMed ID: 31790974
[TBL] [Abstract][Full Text] [Related]
15. Comparison of clinicopathological features and prognosis of papillary thyroid carcinoma and microcarcinoma: A population-based propensity score matching analysis.
Qian B; Hu L; Zhang S; Zhu J; Mei L; Huang T; Qu X
Front Endocrinol (Lausanne); 2022; 13():944758. PubMed ID: 35992148
[TBL] [Abstract][Full Text] [Related]
16. Active Surveillance of Thyroid Microcarcinomas: a Critical View.
Cernea CR; Matos LL; Eugênio C; Ferreira GM; Cerqueira YS; Leite AKN; Vanderlei FAB; de Carlucci D; Gotoda RN; Hojaij FC; Araújo-Filho VJF
Curr Oncol Rep; 2022 Jan; 24(1):69-76. PubMed ID: 35061193
[TBL] [Abstract][Full Text] [Related]
17. Papillary thyroid microcarcinoma: Is active surveillance always enough?
Sutherland R; Tsang V; Clifton-Bligh RJ; Gild ML
Clin Endocrinol (Oxf); 2021 Dec; 95(6):811-817. PubMed ID: 34021503
[TBL] [Abstract][Full Text] [Related]
18. Cost-Effectiveness of Prophylactic Cranial Irradiation Versus MRI Surveillance for Extensive-Stage Small Cell Lung Cancer.
Kim H; Keller A; Beriwal S; Smith KJ; Vargo JA
Int J Radiat Oncol Biol Phys; 2021 Dec; 111(5):1186-1194. PubMed ID: 33984410
[TBL] [Abstract][Full Text] [Related]
19. Surgery alone for papillary thyroid microcarcinoma is less costly and more effective than long term active surveillance.
Lin JF; Jonker PKC; Cunich M; Sidhu SB; Delbridge LW; Glover AR; Learoyd DL; Aniss A; Kruijff S; Sywak MS
Surgery; 2020 Jan; 167(1):110-116. PubMed ID: 31543327
[TBL] [Abstract][Full Text] [Related]
20. The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.
Fox M; Mealing S; Anderson R; Dean J; Stein K; Price A; Taylor RS
Health Technol Assess; 2007 Nov; 11(47):iii-iv, ix-248. PubMed ID: 17999842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]